Schrodinger, Inc. (NASDAQ:SDGR) Given Consensus Recommendation of “Hold” by Brokerages

Schrodinger, Inc. (NASDAQ:SDGR) has been given a consensus recommendation of “Hold” by the eleven ratings firms that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $24.3333.

SDGR has been the topic of several recent analyst reports. TD Cowen decreased their target price on shares of Schrodinger from $33.00 to $24.00 and set a “buy” rating on the stock in a report on Thursday, January 8th. Cowen reiterated a “buy” rating on shares of Schrodinger in a report on Thursday, January 8th. UBS Group assumed coverage on Schrodinger in a research report on Wednesday, January 7th. They issued a “neutral” rating and a $18.00 price objective for the company. The Goldman Sachs Group began coverage on Schrodinger in a research note on Monday, September 29th. They set a “neutral” rating and a $19.00 target price for the company. Finally, Wall Street Zen lowered Schrodinger from a “hold” rating to a “sell” rating in a research note on Saturday, January 10th.

Schrodinger Stock Down 3.9%

Shares of NASDAQ:SDGR opened at $16.79 on Monday. Schrodinger has a 52-week low of $15.99 and a 52-week high of $28.47. The stock has a market cap of $1.24 billion, a P/E ratio of -6.97 and a beta of 1.54. The business has a fifty day moving average of $17.83 and a two-hundred day moving average of $19.38.

Schrodinger (NASDAQ:SDGR) last announced its quarterly earnings results on Wednesday, November 5th. The company reported ($0.45) earnings per share for the quarter, beating the consensus estimate of ($0.72) by $0.27. Schrodinger had a negative net margin of 68.49% and a negative return on equity of 48.24%. The firm had revenue of $54.32 million for the quarter, compared to analysts’ expectations of $50.51 million. During the same quarter in the previous year, the company posted ($0.87) EPS. The company’s revenue was up 53.9% compared to the same quarter last year. On average, equities analysts anticipate that Schrodinger will post -2.37 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Schrodinger by 169.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,357,532 shares of the company’s stock worth $86,018,000 after acquiring an additional 2,737,728 shares during the last quarter. Millennium Management LLC raised its position in Schrodinger by 1,075.8% in the third quarter. Millennium Management LLC now owns 1,551,721 shares of the company’s stock valued at $31,128,000 after purchasing an additional 1,419,750 shares during the period. Lazard Asset Management LLC lifted its stake in Schrodinger by 65.3% during the third quarter. Lazard Asset Management LLC now owns 2,346,441 shares of the company’s stock worth $47,070,000 after purchasing an additional 927,234 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Schrodinger by 24.8% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,554,569 shares of the company’s stock worth $91,365,000 after buying an additional 904,619 shares during the period. Finally, Massachusetts Financial Services Co. MA boosted its position in shares of Schrodinger by 38.7% during the third quarter. Massachusetts Financial Services Co. MA now owns 2,072,433 shares of the company’s stock worth $41,573,000 after buying an additional 577,899 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

About Schrodinger

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.